Market Cap 182.60M
Revenue (ttm) 0.00
Net Income (ttm) -24.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,193,282
Avg Vol 3,043,798
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 12%
Beta -0.98
Analysts Strong Buy
Price Target $2.00

Company Profile

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, United States
cutiesutie
cutiesutie Oct. 27 at 7:33 PM
$SAVA - Dr Wang’s lawyer, Jennifer Beidel: “We’re honored to have fought this case on his behalf.” - Recognizing the toll of the government’s errors and miscarriage of justice, Judge Theodore D. Chuang called the case “regrettable and unfortunate” and apologized on behalf of the justice system, stating, “…I hope anyone who is paying attention to this doesn’t think adversely of our overall justice system. Things happen. But this is not a good example of how things should be done…” https://www.dykema.com/news-insights/dykema-secures-rare-victory-for-medical-scientist-in-closely-watched-research-fraud-case.html?utm_source=chatgpt.com
0 · Reply
holysquish
holysquish Oct. 27 at 5:36 PM
$SAVA Will probably be 20$ soon
1 · Reply
PierceC
PierceC Oct. 27 at 5:27 PM
$SAVA 7-8 soon
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 12:15 PM
Enter: $SAVA Calls Strike Price: $4 Expiry Date: NOV 14 2025 Buy in Price: $0.53 - $0.55 Sell Price: $0.83 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Bazzzigar
Bazzzigar Oct. 27 at 11:59 AM
$SAVA ISPC NAKA
0 · Reply
NJ125
NJ125 Oct. 26 at 9:00 PM
$SAVA court case settled; https://storage.courtlistener.com/recap/gov.uscourts.mdd.562689/gov.uscourts.mdd.562689.139.0.pdf
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 6:22 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SAVA Current Share Price: $3.78 Contracts: $SAVA January 15, 2027 $4 Calls Scale in: $1.58- $1.94 Scale out: $2.46-$3.17 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 26 at 4:29 PM
Enter: $SAVA Calls Strike Price: $4 Expiry Date: NOV 14 2025 Buy in Price: $0.53 - $0.55 Sell Price: $0.83 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
ForestFoxes
ForestFoxes Oct. 26 at 4:05 PM
Some $ANVS shareholders have expressed interest in something that I worked on last year. I am tagging $SAVA because this was a topic of discussion between myself and the CEO of Annovis Bio. I am also tagging $BCRX because quite a few investors also made large investments into Dr. Maccecchini's company (in some part) based on bio99's many bullish posts covering both the science and his target price projections in the near future back in 2021. Also, I want to acknowledge @kevindenver for the conversations we have had and especially to @MayoMobile for his outstanding work covering various biotech companies in this space. Both of you were mentioned in my communications with CEO Maccecchini as an example of the Corp de Esprit regarding your shared conviction in Anavex Life Sciences. What you are about to see is my answer to Dr. Maccecchini regarding her complaint about how ineffective Dr. Marwan Sabbagh's explanation was regarding the mechanism of action (MOA) of Anavex's lead asset, blarcamesine. I discussed the urgent need IMO of an explanation of the MOA for Annovis' lead asset, buntanetap. My comments attached on this 70-page online file were done quickly and I apologize for any errors you might see. If anyone notices any inaccuracies, please let me know and I would be happy to make corrections. Thank you all! P.S. I decided to stop at 70 pages, but there is so much more information. I would not be surprised if such a file would be many tens of thousands of pages long if/when all of the former Annovis Bio CFOs, and others, are involved. https://www.canva.com/design/DAG21zvqskA/CcwU6Rl5oYSjhvEVFEq50Q/view?utm_content=DAG21zvqskA&utm_campaign=designshare&utm_medium=link&utm_source=viewer
2 · Reply
trendyychaser
trendyychaser Oct. 26 at 12:40 AM
Market’s been tricky, but @Invinc1ble been adapting quick. Worth a follow👌 $BB $TRON $SAVA $ERIC Queues
0 · Reply
Latest News on SAVA
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 7 months ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data


Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 10 months ago

Cassava Sciences Provides a Business Update


cutiesutie
cutiesutie Oct. 27 at 7:33 PM
$SAVA - Dr Wang’s lawyer, Jennifer Beidel: “We’re honored to have fought this case on his behalf.” - Recognizing the toll of the government’s errors and miscarriage of justice, Judge Theodore D. Chuang called the case “regrettable and unfortunate” and apologized on behalf of the justice system, stating, “…I hope anyone who is paying attention to this doesn’t think adversely of our overall justice system. Things happen. But this is not a good example of how things should be done…” https://www.dykema.com/news-insights/dykema-secures-rare-victory-for-medical-scientist-in-closely-watched-research-fraud-case.html?utm_source=chatgpt.com
0 · Reply
holysquish
holysquish Oct. 27 at 5:36 PM
$SAVA Will probably be 20$ soon
1 · Reply
PierceC
PierceC Oct. 27 at 5:27 PM
$SAVA 7-8 soon
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 12:15 PM
Enter: $SAVA Calls Strike Price: $4 Expiry Date: NOV 14 2025 Buy in Price: $0.53 - $0.55 Sell Price: $0.83 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Bazzzigar
Bazzzigar Oct. 27 at 11:59 AM
$SAVA ISPC NAKA
0 · Reply
NJ125
NJ125 Oct. 26 at 9:00 PM
$SAVA court case settled; https://storage.courtlistener.com/recap/gov.uscourts.mdd.562689/gov.uscourts.mdd.562689.139.0.pdf
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 6:22 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SAVA Current Share Price: $3.78 Contracts: $SAVA January 15, 2027 $4 Calls Scale in: $1.58- $1.94 Scale out: $2.46-$3.17 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 26 at 4:29 PM
Enter: $SAVA Calls Strike Price: $4 Expiry Date: NOV 14 2025 Buy in Price: $0.53 - $0.55 Sell Price: $0.83 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
ForestFoxes
ForestFoxes Oct. 26 at 4:05 PM
Some $ANVS shareholders have expressed interest in something that I worked on last year. I am tagging $SAVA because this was a topic of discussion between myself and the CEO of Annovis Bio. I am also tagging $BCRX because quite a few investors also made large investments into Dr. Maccecchini's company (in some part) based on bio99's many bullish posts covering both the science and his target price projections in the near future back in 2021. Also, I want to acknowledge @kevindenver for the conversations we have had and especially to @MayoMobile for his outstanding work covering various biotech companies in this space. Both of you were mentioned in my communications with CEO Maccecchini as an example of the Corp de Esprit regarding your shared conviction in Anavex Life Sciences. What you are about to see is my answer to Dr. Maccecchini regarding her complaint about how ineffective Dr. Marwan Sabbagh's explanation was regarding the mechanism of action (MOA) of Anavex's lead asset, blarcamesine. I discussed the urgent need IMO of an explanation of the MOA for Annovis' lead asset, buntanetap. My comments attached on this 70-page online file were done quickly and I apologize for any errors you might see. If anyone notices any inaccuracies, please let me know and I would be happy to make corrections. Thank you all! P.S. I decided to stop at 70 pages, but there is so much more information. I would not be surprised if such a file would be many tens of thousands of pages long if/when all of the former Annovis Bio CFOs, and others, are involved. https://www.canva.com/design/DAG21zvqskA/CcwU6Rl5oYSjhvEVFEq50Q/view?utm_content=DAG21zvqskA&utm_campaign=designshare&utm_medium=link&utm_source=viewer
2 · Reply
trendyychaser
trendyychaser Oct. 26 at 12:40 AM
Market’s been tricky, but @Invinc1ble been adapting quick. Worth a follow👌 $BB $TRON $SAVA $ERIC Queues
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 9:39 PM
Enter: $SAVA Calls Strike Price: $4 Expiry Date: NOV 14 2025 Buy in Price: $0.53 - $0.55 Sell Price: $0.83 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 8:40 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SAVA Current Share Price: $3.78 Contracts: $SAVA January 15, 2027 $4 Calls Scale in: $1.58- $1.94 Scale out: $2.46-$3.17 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
PeterRaslow
PeterRaslow Oct. 25 at 6:57 PM
$SAVA Biggest Scam in Town
1 · Reply
JumpStarting
JumpStarting Oct. 24 at 9:55 PM
$SAVA On October 23, 2025, the United States District Court for the District of Maryland granted the United States’ unopposed motion to dismiss with prejudice the criminal indictment against Hoau-Yan Wang, PhD. Dr. Wang is a former scientific collaborator and advisor to Cassava Sciences, Inc. (“Cassava” or the “Company”) who conducted foundational research relating to the Company's investigational drug, simufilam. Among other things, the dismissed charges had accused Dr. Wang of causing Cassava to submit grant applications to the U.S. National Institutes of Health that allegedly contained false and fraudulent representations about his research and of manipulating or otherwise fabricating research results, including Western Blot images that he prepared. This order permanently terminates the case against Dr. Wang, and future charges related to the dismissed indictment cannot be refiled against Dr. Wang.
1 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:28 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $META $SVRE $SAVA $GEVO 0-!
0 · Reply
PeterRaslow
PeterRaslow Oct. 24 at 7:54 PM
$SAVA Scam and Fraud, this POS will be BK in 2 years WANG should be in Jail Matt Nachtrab should be in Jail Remi Should be in Jail just disgusting
1 · Reply
bigron8671
bigron8671 Oct. 24 at 4:52 PM
$SAVA I'd sue for malicious prosecution now!
0 · Reply
Pimpeanut
Pimpeanut Oct. 24 at 4:41 PM
$SAVA pump and dumb scheme… first they had a cure for Alzheimer’s now it’s a cure for epilepsy 💩💩💩🚽🚽🚽🚽
0 · Reply
MarcoFla99
MarcoFla99 Oct. 24 at 4:33 PM
$SAVA https://www.sec.gov/Archives/edgar/data/1069530/000143774925031674/sava20251024_8k.htm
0 · Reply
holysquish
holysquish Oct. 24 at 2:59 PM
$SAVA Will probably be 20$ soon
1 · Reply
Pimpeanut
Pimpeanut Oct. 24 at 2:22 PM
$SAVA still a pump and dump like it was 3 years ago … come join a real AI medical play in CLOV
0 · Reply
urgetosurge
urgetosurge Oct. 24 at 2:19 PM
$SAVA that press release lacked forward looking affirmation. They could release additional news but it's the buyout regardless that's caused the insider buy and momo imo.
2 · Reply